Search Results - "Ambinder, R"

DARATUMUMAB AND EPOCH FOR HIV+/‐ PLASMABLASTIC LYMPHOMA: A FEASIBILITY STUDY OF THE AIDS MALIGNANCY CONSORTIUM (AMC 105) by Noy, A., Barta, S. K., Tan, C. R., Kwon, D., Baiocchi, R., Rubinstein, P., Ambinder, R.

Get full text

A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors by Low, J S W, Tao, Q, Ng, K M, Goh, H K, Shu, X-S, Woo, W L, Ambinder, R F, Srivastava, G, Shamay, M, Chan, A T C, Popescu, N C, Hsieh, W-S

“…The critical 8p22 tumor suppressor deleted in liver cancer 1 ( DLC1 ) is frequently inactivated by aberrant CpG methylation and/or genetic deletion and…”
Get full text

The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation by SENG, T. J, LOW, J. S. W, RHA, S. Y, TAN, J, HSIEH, W.-S, AMBINDER, R. F, LIN, X, CHAN, A. T. C, TAOL, Q, LIL, H, CUI, Y, GOH, H. K, WONG, M. L. Y, SRIVASTAVA, G, SIDRANSKY, D, CALIFANO, J, STEENBERGEN, R. D. M

“…Identification of tumor suppressor genes (TSG) silenced by methylation uncovers mechanisms of tumorigenesis and identifies new epigenetic tumor markers for…”
Get full text

Gammaherpesviruses and "Hit-and-Run" oncogenesis by Ambinder, R F

Get full text

The same but different: autologous hematopoietic stem cell transplantation for patients with lymphoma and HIV infection by Ambinder, R F

“…In an earlier era, high-dose therapies were thought to be contraindicated in HIV-infected patients. Patients with HIV fared somewhat better with reduced-dose…”
Get full text

Pharmacokinetically-targeted dosed everolimus maintenance therapy in lymphoma patients by Schoch, L. K., Asiama, A., Zahurak, M., Shanbhag, S., Hurtt, J., Sawyer, K., Swinnen, L. J., Wagner-Johnston, N., Jones, R. J., Ambinder, R. F., Gladstone, Douglas E.

“…Background Everolimus, an mTOR inhibitor, is active in refractory lymphomas. However, toxicity with flat dosing limits its usage. Speculatively,…”
Get full text

Epstein–Barr virus associated lymphoproliferations in the AIDS setting by Ambinder, R.F.

“…Epstein–Barr virus (EBV) is a ubiquitous gammaherpesvirus that is associated with a variety of malignancies. In vivo infection of B lymphocytes is initially…”
Get full text

Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma by Ratner, L, Rauch, D, Abel, H, Caruso, B, Noy, A, Barta, S K, Parekh, S, Ramos, J C, Ambinder, R, Phillips, A, Harding, J, Baydoun, H H, Cheng, X, Jacobson, S

Get full text

EXTENDED FOLLOW‐UP OF A PHASE I TRIAL OF IPILIMUMAB, NIVOLUMAB AND BRENTUXIMAB VEDOTIN IN RELAPSED HODGKIN LYMPHOMA: A TRIAL OF THE ECOG‐ACRIN RESEARCH GROUP (E4412) by Diefenbach, C.S., Hong, F., Ambinder, R., Cohen, J., Robertson, M., David, K., Advani, R., Fenske, T., Barta, S., Palmisano, N., Svoboda, J., Morgan, D., Karmali, R., Kahl, B., Ansell, S.

Get full text

Evidence of genetic susceptibility to infectious mononucleosis: a twin study by HWANG, A. E., HAMILTON, A. S., COCKBURN, M. G., AMBINDER, R., ZADNICK, J., BROWN, E. E., MACK, T. M., COZEN, W.

“…Infectious mononucleosis is a clinical manifestation of primary Epstein–Barr virus infection. It is unknown whether genetic factors contribute to risk. To…”
Get full text

HIV specific T cells generated from HIV naive adult and cord blood donors target a range of novel viral epitopes—implications for a cure strategy after allogeneic HSCT and CBT by Patel, S, Lam, S, Sung, J, Cruz, R, Goonetilleke, N, Xu, Y, Kuruc, J, Gay, C, Jones, B, Shpall, E, Margolis, D, Ambinder, R, Bollard, C

Get full text

Chemotherapy for Human Immunodeficiency Virus–Associated Non-Hodgkin’s Lymphoma in Combination With Highly Active Antiretroviral Therapy by RATNER, Lee, LEE, Jeannette, HARRINGTON, William, GROCHOW, Louise, FLEXNER, Charles, TAN, Benjamin, STRAUSS, David, SHENGHUI TANG, REDDEN, David, HAMZEH, Fayez, HERNDIER, Brian, SCADDEN, David, KAPLAN, Lawrence, AMBINDER, Richard, LEVINE, Alexandra

“…This study investigated the efficacy, toxicity, and pharmacokinetic interactions resulting from simultaneous combination chemotherapy and highly active…”
Get full text

SAFETY AND EFFICACY OF COMBINATION OF BRENTUXIMAB VEDOTIN AND NIVOLUMAB IN RELAPSED / REFRACTORY HODGKIN LYMPHOMA: a TRIAL OF THE ECOG‐ACRIN CANCER RESEARCH GROUP (E4412) by Diefenbach, C.S., Hong, F., David, K., Cohen, J., Roberston, M., Advani, R., Palmisano, N., Ambinder, R., Kahl, B., Ansell, S.

Get full text

Long-Term Results of Blood and Marrow Transplantation for Hodgkin’s Lymphoma by AKPEK, Görgün, AMBINDER, Richard F, FUCHS, Ephraim, FLINN, Ian W, O'DONNELL, Paul, SEIFTER, Eric J, MANN, Risa B, JONES, Richard J, PIANTADOSI, Steven, ABRAMS, Ross A, BRODSKY, Robert A, VOGELSANG, Georgia B, ZAHURAK, Marianna L, FULLER, Donald, MILLER, Carole B, NOGA, Stephen J

“…To evaluate the long-term outcome after allogeneic (allo) and autologous (auto) blood or marrow transplantation (BMT) in patients with relapsed or refractory…”
Get full text

Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma by Kasamon, Y.L., Jones, R.J., Brodsky, R.A., Fuchs, E.J., Matsui, W., Luznik, L., Powell, J.D., Blackford, A.L., Goodrich, A., Gocke, C.D., Abrams, R.A., Ambinder, R.F., Flinn, I.W.

“…Rituximab may improve transplant outcomes but may delay immunologic recovery. Seventy-seven patients with low-grade or mantle cell lymphoma received autologous…”
Get full text

Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial by Blackstein, M, Vogel, C L, Ambinder, R, Cowan, J, Iglesias, J, Melemed, A

“…This phase II study was conducted to evaluate the efficacy and safety of gemcitabine in patients with metastatic breast cancer (MBC). Women with histologically…”
Get more information

A New Primary Effusion Lymphoma-Derived Cell Line Yields a Highly Infectious Kaposi's Sarcoma Herpesvirus-Containing Supernatant by Cannon, J S, Ciufo, D, Hawkins, A L, Griffin, C A, Borowitz, M J, Hayward, G S, Ambinder, R F

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Linkage between STAT Regulation and Epstein-Barr Virus Gene Expression in Tumors by Chen, H, Lee, J M, Zong, Y, Borowitz, M, Ng, M H, Ambinder, R F, Hayward, S D

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Epstein‐Barr virus‐associated Hodgkin's disease: Epidemiologic characteristics in international data by Glaser, Sally L., Lin, Ruby J., Stewart, Susan L., Ambinder, Richard F., Jarrett, Ruth F., Brousset, Pierre, Pallesen, Gorm, Gulley, Margaret L., Khan, Gulfaraz, O'Grady, Jane, Hummel, Michael, Preciado, Maria Victoria, Knecht, Hans, Chan, John K.C., Claviez, Alexander

“…Hodgkin's disease (HD) has long been suspected to have an infectious precursor, and indirect evidence has implicated Epstein‐Barr virus (EBV), a ubiquitous…”
Get full text

Lytic Viral Replication as a Contributor to the Detection of Epstein-Barr Virus in Breast Cancer by Huang, J, Chen, H, Hutt-Fletcher, L, Ambinder, R F, Hayward, S D

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text